These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5808493)

  • 1. Paradoxical drug reactions and the biochemical analysis of human disease.
    Zakim D
    Gastroenterology; 1969 Sep; 57(3):357-62. PubMed ID: 5808493
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis.
    Schaffner F
    Gastroenterology; 1969 Sep; 57(3):253-5. PubMed ID: 5808484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of plasma lipoprotein components assessed by ultracentrifugation in primary biliary cirrhosis and chronic hepatitis.
    Tacikowski T; Milewski B; Dzieniszewski J; Nowicka G; Walewska-Zielecka B
    Med Sci Monit; 2000; 6(2):325-9. PubMed ID: 11208331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How does fenofibrate exert its cholesterol-lowering effect? (author's transl)].
    Wülfert E
    Nouv Presse Med; 1980 Dec; 9(49):3733-6. PubMed ID: 7208339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study.
    Nakai S; Masaki T; Kurokohchi K; Deguchi A; Nishioka M
    Am J Gastroenterol; 2000 Jan; 95(1):326-7. PubMed ID: 10638623
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical mechanisms of drug action: what does it take for success?
    Swinney DC
    Nat Rev Drug Discov; 2004 Sep; 3(9):801-8. PubMed ID: 15340390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholesterol in primary biliary cirrhosis.
    Schaffner E
    Gastroenterology; 1969 Jun; 56(6):1111-3. PubMed ID: 5788915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of geomedical relations and some humoral findings in Charcot's disease].
    Kovarík J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1966; 9(1):Suppl:213-27. PubMed ID: 5234060
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of carcinogenic action of therapeutic agents].
    Karkos J
    Pol Tyg Lek; 1971 Jun; 26(24):922-5. PubMed ID: 4934778
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis.
    Akbar SM; Furukawa S; Nakanishi S; Abe M; Horiike N; Onji M
    J Gastroenterol; 2005 Feb; 40(2):157-63. PubMed ID: 15770399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of hyperlipidemias].
    Wolfram G
    Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medications and sexuality].
    Droupy S
    Prog Urol; 2002 Sep; 12(2 Spec No):24-8. PubMed ID: 12469480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary prevention of cardiovascular diseases by lowering lipids].
    Klose G
    Internist (Berl); 1997 Jun; 38(6):615-6. PubMed ID: 9265009
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet.
    Sandhya VG; Rajamohan T
    Food Chem Toxicol; 2008 Dec; 46(12):3586-92. PubMed ID: 18809454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneous effect of liver transplantation on the granuloma-enhancing factor of primary biliary cirrhosis.
    Munoz SJ; Patrick H; Moritz M
    Transplant Proc; 1993 Apr; 25(2):1927-9. PubMed ID: 8470230
    [No Abstract]   [Full Text] [Related]  

  • 20. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.